Abstract:Mature myelinating oligodendrocytes have distinct energetic and metabolic requirements compared to neurons. In demyelinating diseases, metabolic stress is a potential cause of oligodendrocyte injury. To understand the pathophysiology that results from metabolic impairments in these disorders it is crucial to investigate oligodendrocyte energy metabolism and the relationship between oligodendrocytes and neighboring cells, in particular the cells that make up the neurovascular unit. Here, we review the properties of oligodendrocyte energy metabolism and address the disruption of metabolic energy in demyelinating diseases. Understanding these molecular mechanisms and cellular relationships aims to identify potential targets for treatments to promote remyelination and recovery. Mature myelinating oligodendrocytes, the cells that produce the myelin sheath that insulates axons in the central nervous system, have distinct energetic and metabolic requirements compared to neurons. Neurons require substantial energy to execute action potentials, while the energy needs of oligodendrocytes are directed toward building the lipid‐rich components of myelin and supporting neuronal metabolism by transferring glycolytic products to axons as additional fuel. The utilization of energy metabolites in the brain parenchyma is tightly regulated to meet the needs of different cell types. Disruption of the supply of metabolites can lead to stress and oligodendrocyte injury, contributing to various neurological disorders, including some demyelinating diseases. Understanding the physiological properties, structures, and mechanisms involved in oligodendrocyte energy metabolism, as well as the relationship between oligodendrocytes and neighboring cells, is crucial to investigate the underlying pathophysiology caused by metabolic impairment in these disorders. In this review, we describe the particular physiological properties of oligodendrocyte energy metabolism and the response of oligodendrocytes to metabolic stress. We delineate the relationship between oligodendrocytes and other cells in the context of the neurovascular unit, and the regulation of metabolite supply according to energetic needs. We focus on the specific bioenergetic requirements of oligodendrocytes and address the disruption of metabolic energy in demyelinating diseases. We encourage further studies to increase understanding of the significance of metabolic stress on oligodendrocyte injury, to support the development of novel therapeutic approaches for the treatment of demyelinating diseases.

Chronic oligodendrocyte injury in central nervous system pathologies

Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury

Oligodendrocytes and myelin: Active players in neurodegenerative brains?

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis

Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration

Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration

Beyond Myelination: Possible Roles of the Immune Proteasome in Oligodendroglial Homeostasis and Dysfunction

Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair

Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair

Translating Molecular Approaches to Oligodendrocyte-Mediated Neurological Circuit Modulation

From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease

CNS macrophage contributions to myelin health

New Insights into the Immunologic Role of Oligodendrocyte Lineage Cells in Demyelination Diseases

Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?

Clinical implications of myelin regeneration in the central nervous system

Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases.

Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair

Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.

Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases

Damage to Myelin and Oligodendrocytes: A Role in Chronic Outcomes Following Traumatic Brain Injury?

Astrocyte-Oligodendrocyte interaction regulates central nervous system regeneration